Cleared Traditional

K953569 - COURIER BALLOON DILATATION CATHETER

K953569 is an FDA 510(k) clearance for COURIER BALLOON DILATATION CATHETER, manufactured by Boston Scientific Corp. The device is a Class 2 Cardiovascular device with product code LIT cleared through the Traditional 510(k) pathway after a 142-day FDA review.

K953569 · Boston Scientific Corp · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1995
Decision
142d
Days
Class 2
Risk

K953569 is an FDA 510(k) clearance for the COURIER BALLOON DILATATION CATHETER. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Boston Scientific Corp (Natick,, US). The FDA issued a Cleared decision on December 20, 1995 after a review of 142 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Boston Scientific Corp devices

FDA 510(k) Submission Details - K953569

510(k) Number K953569 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 31, 1995
Decision Date December 20, 1995
Days to Decision 142 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d slower than avg
Panel avg: 125d · This submission: 142d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LIT Device Classification - Class 2, Special Controls

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 345
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K953569.
MEGA PTA BALLOON CATHETER
K955886 · Cordis Corp. · Mar 1996
NOPROFILE OLBERT CATHETER SYSTEM BALLOON DILATATION CATHETER
K952884 · Meadox Medicals, Div. Boston Scientific Corp. · Feb 1996
MS CLASSIQUE BALLOON DIATATION CATHETER
K953298 · Meadox Medicals, Div. Boston Scientific Corp. · Feb 1996
NOPROFILE OLBERT CATHETER SYSTEM BALLOON DILATATION CATHETER
K953608 · Meadox Medicals, Div. Boston Scientific Corp. · Dec 1995
XXL BALLON DILATATION CATHETER
K952063 · Boston Scientific Corp · Nov 1995
SYMMETRY SMALL VESSEL BALLOON DILATATION CATHETER
K953602 · Boston Scientific Corp · Oct 1995